Researchers examined the ability of proxalutamide, an androgen receptor antagonist, to impact SARS-CoV-2 infection and downstream inflammatory responses.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
Home Newsletters Immunology of Infectious Disease News Proxalutamide Reduces SARS-CoV-2 Infection and Associated Inflammatory Response
